Clinical and scientific aspects of muscle-specific tyrosine kinase-related myasthenia gravis

Muscle-specific kinase (MuSK) autoantibodies suppress the MuSK pathway and ACh receptor retention at the mouse neuromuscular junction

(2014) Nazanin Ghazanfari et al.   JOURNAL OF PHYSIOLOGY-LONDON

Autoantibodies to Agrin in Myasthenia Gravis Patients

(2014) Bin Zhang et al.   PLoS One

Effects of the ß2-Adrenoceptor Agonist, Albuterol, in a Mouse Model of Anti-MuSK Myasthenia Gravis

(2014) Nazanin Ghazanfari et al.   PLoS One

Association of HLA-DRB1∗14, -DRB1∗16 and -DQB1∗05 with MuSK-myasthenia gravis in patients from Turkey

(2013) Mahdi Alahgholi-Hajibehzad et al.   HUMAN IMMUNOLOGY

A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis

(2013) P. Zisimopoulou et al.   JOURNAL OF AUTOIMMUNITY

Pyridostigmine but not 3,4-diaminopyridine exacerbates ACh receptor loss and myasthenia induced in mice by muscle-specific kinase autoantibody

(2013) Marco Morsch et al.   JOURNAL OF PHYSIOLOGY-LONDON

Muscle specific kinase autoimmune myasthenia gravis in children: A case series

(2013) Karen L. Skjei et al.   NEUROMUSCULAR DISORDERS

MuSK Myasthenia Gravis IgG4 Disrupts the Interaction of LRP4 with MuSK but Both IgG4 and IgG1-3 Can Disperse Preformed Agrin-Independent AChR Clusters

(2013) Inga Koneczny et al.   PLoS One

MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4

(2013) M. G. Huijbers et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The search for new antigenic targets in myasthenia gravis

(2012) Judith Cossins et al.   Annals of the New York Academy of Sciences

Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice

(2012) Rinse Klooster et al.   BRAIN

Muscle specific kinase autoantibodies cause synaptic failure through progressive wastage of postsynaptic acetylcholine receptors

(2012) Marco Morsch et al.   EXPERIMENTAL NEUROLOGY

Passive and active immunization models of MuSK-Ab positive myasthenia: Electrophysiological evidence for pre and postsynaptic defects

(2012) Stuart Viegas et al.   EXPERIMENTAL NEUROLOGY

Divalent and monovalent autoantibodies cause dysfunction of MuSK by distinct mechanisms in a rabbit model of myasthenia gravis

(2012) Shuuichi Mori et al.   JOURNAL OF NEUROIMMUNOLOGY

A Retrospective study of complications of therapeutic plasma exchange in myasthenia

(2012) Jeffrey T. Guptill et al.   MUSCLE & NERVE

Antibodies against Muscle-Specific Kinase Impair Both Presynaptic and Postsynaptic Functions in a Murine Model of Myasthenia Gravis

(2011) Shuuichi Mori et al.   AMERICAN JOURNAL OF PATHOLOGY

Acute Severe Animal Model of Anti–Muscle-Specific Kinase Myasthenia

(2011) Kayoko Nishi   ARCHIVES OF NEUROLOGY

Managing the risks of immunosuppression

(2011) D Sean Riminton et al.   CURRENT OPINION IN NEUROLOGY

Muscle-selective synaptic disassembly and reorganization in MuSK antibody positive MG mice

(2011) Anna Rostedt Punga et al.   EXPERIMENTAL NEUROLOGY

Anti-musk antibody myasthenia gravis: Clinical findings and response to treatment in two large cohorts

(2011) Jeffrey T. Guptill et al.   MUSCLE & NERVE

Beneficial effects of albuterol in congenital endplate acetylcholinesterase deficiency and Dok-7 myasthenia

(2011) Teerin Liewluck et al.   MUSCLE & NERVE

Anti-MuSK autoantibodies block binding of collagen Q to MuSK

(2011) Y. Kawakami et al.   NEUROLOGY

Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis

(2010) Osamu Higuchi et al.   ANNALS OF NEUROLOGY

A systematic review of population based epidemiological studies in Myasthenia Gravis

(2010) Aisling S Carr et al.   BMC Neurology

Update on muscle-specific tyrosine kinase antibody positive myasthenia gravis

(2010) Jeffrey T Guptill et al.   CURRENT OPINION IN NEUROLOGY

Mutations in MUSK causing congenital myasthenic syndrome impair MuSK–Dok-7 interaction

(2010) Ricardo A. Maselli et al.   HUMAN MOLECULAR GENETICS

Muscle Specific Kinase: Organiser of synaptic membrane domains

(2010) Nazanin Ghazanfari et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Patient autoantibodies deplete postsynaptic muscle-specific kinase leading to disassembly of the ACh receptor scaffold and myasthenia gravis in mice

(2010) R. N. Cole et al.   JOURNAL OF PHYSIOLOGY-LONDON

Ephedrine treatment in congenital myasthenic syndrome due to mutations in DOK7

(2010) D. Lashley et al.   NEUROLOGY

Clinical findings in MuSK-antibody positive myasthenia gravis: A U.S. experience

(2009) Mamatha Pasnoor et al.   MUSCLE & NERVE

Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction

(2008) Rebecca N. Cole et al.   ANNALS OF NEUROLOGY

Response to Therapy in Myasthenia Gravis with Anti-MuSK Antibodies

(2008) Amelia Evoli et al.   Annals of the New York Academy of Sciences

Myasthenia Gravis Seronegative for Acetylcholine Receptor Antibodies

(2008) Angela Vincent et al.   Annals of the New York Academy of Sciences

IgG1 antibodies to acetylcholine receptors in ‘seronegative’ myasthenia gravis†

(2008) Maria Isabel Leite et al.   BRAIN

MuSK-antibody positive myasthenia gravis: Questions from the clinic

(2008) Donald B. Sanders et al.   JOURNAL OF NEUROIMMUNOLOGY